Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine EXG-5003 against SARS-CoV-2.
Vaccines (Basel). 2023 Nov 27;11(12):1767. doi: 10.3390/vaccines11121767.
Vaccines (Basel). 2023.
PMID: 38140172
Free PMC article.
Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity.
Amano T, Yu H, Amano M, Leyder E, Badiola M, Ray P, Kim J, Ko AC, Achour A, Weng NP, Kochba E, Levin Y, Ko MSH.
Amano T, et al. Among authors: badiola m.
iScience. 2023 Mar 5;26(4):106335. doi: 10.1016/j.isci.2023.106335. eCollection 2023 Apr 21.
iScience. 2023.
PMID: 36968065
Free PMC article.
Item in Clipboard
Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity.
Amano T, Yu H, Amano M, Leyder E, Badiola M, Ray P, Kim J, Ko AC, Achour A, Weng NP, Kochba E, Levin Y, Ko MSH.
Amano T, et al. Among authors: badiola m.
bioRxiv [Preprint]. 2022 Sep 6:2022.09.05.506686. doi: 10.1101/2022.09.05.506686.
bioRxiv. 2022.
PMID: 36263074
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Cite
Cite